Myriad data.
Individual care.
Emyria_Logo_Panel

We Are

A clinical-stage biotech company developing multiple new treatments for unmet medical needs. Our treatments use ethically-sourced data powered by real patients at our innovative clinics.

Clinical Pathway May 2022

FOR INVESTORS

Ours is a collaborative vision and venture. We’re bringing people and partners together for the greater good: patients, clinicians, researchers, medical innovators and, of course, investors.

Our Real-World Data model allows us to fast-track the clinical trial process. That means we can create and produce new medical treatments quickly and effectively.
75 %
FDA approvals where real-world evidence (RWE) was provided, and growing.
1000 +
Unique data points collected per patient.
$ 3 T USD
Trillion USD cost of chronic disease and mental health per year in the US.
Call 1300 436 363Contact